Association between medication possession ratio, virologic failure and drug resistance in HIV-1-infected adults on antiretroviral therapy in Côte d'Ivoire

Journal of Acquired Immune Deficiency Syndromes

Volumn 56, Issue 4, 2011, Pages 356-364

  Messou, Eugène ^a,b   Chaix, Marie Laure ^c   Gabillard, Delphine ^a,b   Minga, Albert ^a,b   Losina, Elena ^d   Yapo, Vincent ^a,e   Kouakou, Martial ^a   Danel, Christine ^a,b   Sloan, Caroline ^a   Rouzioux, Christine ^c   Freedberg, Kenneth A ^d   Anglaret, Xavier ^a,b  

^a Programme PAC CI/ANRS   (Côte d’Ivoire)

^b UNIVERSITÉ DE BORDEAUX   (France)

^c UNIVERSITÉ PARIS DESCARTES   (France)

^d MASSACHUSETTS GENERAL HOSPITAL   (United States)

^e CENTRE HOSPITALIER UNIVERSITAIRE DE TREICHVILLE   (Côte d’Ivoire)

Author keywords

[No Author keywords available]

Indexed keywords

EFAVIRENZ; EMTRICITABINE; ETRAVIRINE; LAMIVUDINE; NEVIRAPINE; NONNUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITOR; RNA DIRECTED DNA POLYMERASE INHIBITOR; STAVUDINE; VIRUS RNA; ZIDOVUDINE;

ADULT; ANALYTICAL PARAMETERS; ANTIVIRAL RESISTANCE; ARTICLE; CD4 LYMPHOCYTE COUNT; COHORT ANALYSIS; COMPUTER SYSTEM; CONTROLLED STUDY; COTE D'IVOIRE; DRUG TREATMENT FAILURE; EARLY INTERVENTION; FEMALE; FOLLOW UP; GENOTYPE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; MAJOR CLINICAL STUDY; MALE; MEDICATION POSSESSION RATIO; PATIENT COMPLIANCE; PATIENT MONITORING; PRIORITY JOURNAL; PROSPECTIVE STUDY; VIRUS INHIBITION; VIRUS LOAD; VIRUS MUTATION;

EID: 79952446770     PISSN: 15254135     EISSN: None     Source Type: Journal    
DOI: 10.1097/QAI.0b013e3182084b5a     Document Type: Article

References (22)

1. Chene G, Sterne JA, May M, et al. Prognostic importance of initial response in HIV-1 infected patients starting potent antiretroviral therapy: analysis of prospective studies. Lancet. 2003;362:679-686.
2. Fielding KL, Charalambous S, Stenson AL, et al. Risk factors for poor virological outcome at 12 months in a workplace-based antiretroviral therapy programme in South Africa: a cohort study. BMC Infect Dis. 2008; 8:93.
3. Hanson DL, Adje-Toure C, Talla-Nzussouo N, et al. HIV type 1 drug resistance in adults receiving highly active antiretroviral therapy in Abidjan, Cote d'Ivoire. AIDS Res Hum Retroviruses. 2009;25:489-495.
4. Bangsberg DR. Preventing HIV antiretroviral resistance through better monitoring of treatment adherence. J Infect Dis. 2008;197(Suppl 3): S272-S278. (Pubitemid 351717317)
5. Danel C, Gabillard D, Inwoley A, et al.Medium-term probability of success of antiretroviral treatment after early warning signs of treatment failure in West African adults. AIDS Res Hum Retroviruses. 2009;25:783-793.
6. Carrieri P, Cailleton V, Le Moing V, et al. The dynamic of adherence to highly active antiretroviral therapy: results from the French National APROCO cohort. J Acquir Immune Defic Syndr. 2001;28:232-239. (Pubitemid 33055448)
7. Rueda S, Park-Wyllie LY, Bayoumi AM, et al. Patient support and education for promoting adherence to highly active antiretroviral therapy for HIV/AIDS. Cochrane Database Syst Rev. 2006;(3):CD001442.
8. Miller LG, Hays RD. Adherence to combination antiretroviral therapy: synthesis of the literature and clinical implications. AIDS Read. 2000;10: 177-185. (Pubitemid 30164998)
9. Kouanfack C, Laurent C, Peytavin G, et al. Adherence to antiretroviral therapy assessed by drug level monitoring and self-report in cameroon. J Acquir Immune Defic Syndr. 2008;48:216-219.
10. Kredo T, Van der Walt JS, Siegfried N, et al. Therapeutic drug monitoring of antiretrovirals for people with HIV. Cochrane Database Syst Rev. 2009; (3):CD007268.
11. Diabate S, Alary M, Koffi CK. Determinants of adherence to highly active antiretroviral therapy among HIV-1-infected patients in Cote d'Ivoire. AIDS. 2007;21:1799-1803. (Pubitemid 47237568)
12. Ramadhani HO, Thielman NM, Landman KZ, et al. Predictors of incomplete adherence, virologic failure, and antiviral drug resistance among HIV-infected adults receiving antiretroviral therapy in Tanzania. Clin Infect Dis. 2007;45:1492-1498. (Pubitemid 351411882)
13. Eholie SP, Tanon A, Polneau S, et al. Field adherence to highly active antiretroviral therapy in HIV-infected adults in Abidjan, Cote d'Ivoire. J Acquir Immune Defic Syndr. 2007;45:355-358. (Pubitemid 47012385)
14. Bisson GP, Gross R, Bellamy S, et al. Pharmacy refill adherence compared with CD4 count changes for monitoring HIV-infected adults on antiretroviral therapy. PLoS Med. 2008;5:e109.
15. Kitahata MM, Reed SD, Dillingham PW, et al. Pharmacy-based assessment of adherence to HAART predicts virologic and immunologic treatment response and clinical progression to AIDS and death. Int J STD AIDS. 2004;15:803-810. (Pubitemid 40018704)
16. Nachega JB, Hislop M, Dowdy DW, et al. Adherence to highly active antiretroviral therapy assessed by pharmacy claims predicts survival in HIVinfected South African adults. J Acquir Immune Defic Syndr. 2006;43:78-84. (Pubitemid 44306492)
17. Steiner JF, Prochazka AV. The assessment of refill compliance using pharmacy records: methods, validity, and applications. J Clin Epidemiol. 1997;50:105-116. (Pubitemid 27089212)
18. Goldman JD, Cantrell RA, Mulenga LB, et al. Simple adherence assessments to predict virologic failure among HIV-infected adults with discordant immunologic and clinical responses to antiretroviral therapy. AIDS Res Hum Retroviruses. 2008;24:1031-1035.
19. Nachega JB, Hislop M, Dowdy DW, et al. Adherence to nonnucleoside reverse transcriptase inhibitor-based HIV therapy and virologic outcomes. Ann Intern Med. 2007;146:564-573. (Pubitemid 351650537)
20. Gross R, Yip B, Lo Re V III, et al. A simple, dynamic measure of antiretroviral therapy adherence predicts failure to maintain HIV-1 suppression. J Infect Dis. 2006;194:1108-1114. (Pubitemid 44547650)
21. Acri T, Tenhave TR, Chapman JC, et al. Lack of association between retrospectively collected pharmacy refill data and electronic drug monitoring of antiretroviral adherence. AIDS Behav. 2010;14:748-754.
22. Messou E, Anglaret X, Duvignac J, et al. Antiretroviral treatment changes in adults from Cote d'Ivoire: the roles of tuberculosis and pregnancy. AIDS. 2010;24:93-99.